CryoLife, Inc. (NYSE:CRY) manufactures, processes, and distributes medical devices and implantable living tissues used in cardiac and vascular surgical procedures. From mid-April until early October, the stock has done well, rising over 60%. Since then however, the share price dropped 20% due to a disappointing Q3 earnings report and lowered full-year guidance, resulting at least partially from the negative impact of recent hurricanes. The share price further plummeted after the company announced a $225 million acquisition of JOTEC, German-based, privately-held developer of technologically differentiated endovascular stent grafts.
CRY data by YCharts
Top Medical Stocks To Own For 2019: Alexandria Real Estate Equities, Inc.(ARE)
Advisors' Opinion:- [By Shane Hupp]
Alexandria Real Estate Equities Inc (NYSE:ARE) Director Maria C. Freire sold 3,000 shares of the stock in a transaction that occurred on Thursday, August 16th. The stock was sold at an average price of $128.67, for a total transaction of $386,010.00. Following the transaction, the director now owns 3,344 shares in the company, valued at approximately $430,272.48. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
- [By Logan Wallace]
Alexandria Real Estate Equities (NYSE:ARE) issued an update on its FY19 earnings guidance on Monday morning. The company provided earnings per share guidance of $6.85-$7.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.94. Alexandria Real Estate Equities also updated its FY 2019 guidance to $6.85-7.05 EPS.
- [By Stephan Byrd]
Aecon Group Inc. (TSE:ARE) – Stock analysts at Desjardins cut their FY2018 earnings estimates for Aecon Group in a research note issued to investors on Thursday, May 24th. Desjardins analyst B. Poirier now forecasts that the company will post earnings of $0.96 per share for the year, down from their prior forecast of $1.14. Desjardins currently has a “Buy” rating on the stock.
- [By Joseph Griffin]
Alexandria Real Estate Equities Inc (NYSE:ARE) insider Dean A. Shigenaga sold 9,000 shares of the business’s stock in a transaction dated Monday, August 20th. The shares were sold at an average price of $129.59, for a total value of $1,166,310.00. Following the completion of the transaction, the insider now directly owns 148,645 shares of the company’s stock, valued at approximately $19,262,905.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Top Medical Stocks To Own For 2019: Era Group, Inc.(ERA)
Advisors' Opinion:- [By Logan Wallace]
ERA (CURRENCY:ERA) traded down 12.1% against the US dollar during the 1 day period ending at 22:00 PM ET on June 30th. One ERA coin can currently be purchased for about $0.0073 or 0.00000115 BTC on popular exchanges including CoinExchange and Cryptohub. Over the last week, ERA has traded 1.6% lower against the US dollar. ERA has a market capitalization of $0.00 and approximately $299.00 worth of ERA was traded on exchanges in the last day.
- [By Logan Wallace]
Media stories about Era Group (NYSE:ERA) have been trending somewhat positive recently, Accern reports. Accern ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Era Group earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned headlines about the transportation company an impact score of 47.38255838638 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
- [By Logan Wallace]
Era Group (NYSE:ERA) was upgraded by research analysts at ValuEngine from a “hold” rating to a “buy” rating in a report released on Saturday.
Top Medical Stocks To Own For 2019: Mitek Systems, Inc.(MITK)
Advisors' Opinion:- [By ]
Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
- [By Evan Niu, CFA]
Shares of Mitek (NASDAQ:MITK) have plunged today, down by 17% as of 11:50 a.m. EDT, after the company announced two major executive transitions. The digital identity specialist is losing both its CEO and CFO.
- [By Shane Hupp]
Paradigm Capital Management Inc. NY lifted its stake in shares of Mitek Systems, Inc. (NASDAQ:MITK) by 243.9% during the 2nd quarter, Holdings Channel reports. The firm owned 141,000 shares of the software maker’s stock after purchasing an additional 100,000 shares during the quarter. Paradigm Capital Management Inc. NY’s holdings in Mitek Systems were worth $1,255,000 at the end of the most recent reporting period.
- [By Motley Fool Staff]
Many consumers prefer to deposit a check on their smartphone instead of visiting a bank branch or ATM in person. However, most banks lack the technological know-how to make this process work. That's why thousands of them have partnered with Mitek Systems (NASDAQ:MITK), a leading provider of image capture and identity verification software that makes it possible for banks to offer this must-have service to their customers.
Top Medical Stocks To Own For 2019: Lydall, Inc.(LDL)
Advisors' Opinion:- [By Shane Hupp]
Russell Investments Group Ltd. boosted its holdings in Lydall, Inc. (NYSE:LDL) by 32.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 65,955 shares of the auto parts company’s stock after purchasing an additional 16,152 shares during the period. Russell Investments Group Ltd. owned approximately 0.38% of Lydall worth $2,879,000 at the end of the most recent reporting period.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Lydall (LDL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Motley Fool Transcribers]
Lydall Inc. (NYSE:LDL)Q4 2018 Earnings Conference CallFeb. 26, 2019, 10:00 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Logan Wallace]
Northern Trust Corp lowered its position in shares of Lydall, Inc. (NYSE:LDL) by 1.6% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 231,008 shares of the auto parts company’s stock after selling 3,798 shares during the quarter. Northern Trust Corp’s holdings in Lydall were worth $11,147,000 as of its most recent filing with the Securities & Exchange Commission.
- [By Daniel Miller]
Shares of Lydall (NYSE:LDL), a global manufacturer of specialty engineered products for the thermal/acoustical (primarily in vehicles) and filtration/separation markets, jumped as high as 11.9% Tuesday morning after the company released fourth-quarter results.
Top Medical Stocks To Own For 2019: Olympic Steel Inc.(ZEUS)
Advisors' Opinion:- [By Stephan Byrd]
Olympic Steel, Inc. (NASDAQ:ZEUS) – Jefferies Financial Group boosted their Q2 2018 earnings per share (EPS) estimates for Olympic Steel in a report released on Tuesday, July 10th. Jefferies Financial Group analyst S. Rosenfeld now anticipates that the basic materials company will earn $1.01 per share for the quarter, up from their previous forecast of $0.90. Jefferies Financial Group also issued estimates for Olympic Steel’s Q3 2018 earnings at $0.50 EPS, Q4 2018 earnings at $0.09 EPS, FY2018 earnings at $2.29 EPS and FY2019 earnings at $2.37 EPS.
- [By Max Byerly]
Get a free copy of the Zacks research report on Olympic Steel (ZEUS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Headlines about Olympic Steel (NASDAQ:ZEUS) have been trending somewhat positive on Tuesday, Accern reports. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Olympic Steel earned a news sentiment score of 0.13 on Accern’s scale. Accern also gave news coverage about the basic materials company an impact score of 47.5465348320487 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
- [By Joseph Griffin]
Olympic Steel (NASDAQ:ZEUS) was downgraded by investment analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Friday.
Top Medical Stocks To Own For 2019: Cherokee Inc.(CHKE)
Advisors' Opinion:- [By Shane Hupp]
Cherokee (NASDAQ:CHKE) released its quarterly earnings data on Thursday. The company reported ($0.20) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.09) by ($0.11), RTT News reports. Cherokee had a negative return on equity of 13.63% and a negative net margin of 130.24%. During the same quarter last year, the business posted ($0.07) earnings per share.
- [By Max Byerly]
Headlines about Cherokee (NASDAQ:CHKE) have trended positive on Thursday, Accern Sentiment reports. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cherokee earned a media sentiment score of 0.32 on Accern’s scale. Accern also assigned media stories about the company an impact score of 44.2075854049616 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
- [By Money Morning Staff Reports]
Last week's top performing penny stock, Cherokee Inc. (Nasdaq: CHKE), jumped over 90% after the company secured a $40 million three-year financing agreement that will allow the company to refinance its debt.
- [By Money Morning News Team]
The 90% gainer was Cherokee Inc. (NASDAQ: CHKE), whose skyrocketing price was the result of its securing a deal to refinance its corporate debt. The deal is a three-year agreement worth $40 million.
- [By Max Byerly]
Cherokee (NASDAQ: CHKE) and J.Jill (NYSE:JILL) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.
- [By Garrett Baldwin]
Following the June FOMC meeting, silver prices are hovering at very attractive price levels. With interest rates heading higher, it's going to be a very good time for silver hounds to buy on the dip and deliver incredible profits in the months ahead. Learn more right here.
The Top Stock Market Stories for Thursday On Thursday, the European Central Bank held its meeting in Latvia to discuss the future of its quantitative easing program. The central bank of the world's largest economic bloc said that it will likely end its quantitative easing program in December. This represents an extension beyond the current plan to end the stimulus program in September. ECB President Mario Draghi said the program would be reduced to 15 billion euros each month during the final three months of the year. Yesterday, the U.S. Federal Reserve raised interest rates for the second time in 2018. The central bank said that economic growth has been rising at a solid rate and hinted that it could raise rates two more times this year. Fed Chair Jerome Powell did raise an alarm on Wednesday after stating that companies are holding back on investment due to ongoing concerns about U.S. President Donald Trump's trade policies. Trump is expected to decide this week on whether to proceed with tariffs on about $50 billion in Chinese goods. Trade tensions are heating up again. This morning, China announced it would call off its deal to avoid a trade war if the Trump administration proceeds with tariffs on Friday morning. Tomorrow, the Trump team will decide if it will hit China with tariffs on roughly $50 billion in goods. Stocks to Watch Today: ADBE, CMCSA, TSLA, MSFT Adobe Systems Inc. (Nasdaq: ADBE) will report earnings after the bell Thursday. The software giant is expected to report earnings per share of $1.54 on top of $2.15 billion in revenue. Insider buying is alive and well at Tesla Inc. (Nasdaq: TSLA). Chair and CEO Elon Musk purchased $25 million in company stock, according to a
No comments:
Post a Comment